Mometasone Furoate Spray, Metered
FDA Label NDC 65162-891

36 label sections · Submitted to the FDA by Amneal Pharmaceuticals Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amneal Pharmaceuticals Llc for the product Mometasone Furoate (NDC 65162-891). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1 prophylaxis of seasonal allergic rhinitis, 1.2 treatment of chronic rhinosinusitis with nasal polyps, 2.1 preparation and administration, 2.2 recommended dosage for prophylaxis of seasonal allergic rhinitis, 2.3 recommended dosage for treatment of chronic rhinosinusitis with nasal polyps, 3 dosage forms and strengths, 4 contraindications, 5.1 local nasal adverse reactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.